{"organizations": [], "uuid": "78ff8cb3f4ee0598f4b127868f0d39ccad162351", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ophthotech-targets-gene-therapy-to/brief-ophthotech-targets-gene-therapy-to-expand-its-orphan-and-age-related-retinal-disease-strategy-idUSFWN1QH0QH", "country": "US", "domain_rank": 408, "title": "BRIEF-Ophthotech Targets Gene Therapy To Expand Its Orphan And Age-Related Retinal Disease Strategy", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.888, "site_type": "news", "published": "2018-02-27T19:39:00.000+02:00", "replies_count": 0, "uuid": "78ff8cb3f4ee0598f4b127868f0d39ccad162351"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ophthotech-targets-gene-therapy-to/brief-ophthotech-targets-gene-therapy-to-expand-its-orphan-and-age-related-retinal-disease-strategy-idUSFWN1QH0QH", "ord_in_thread": 0, "title": "BRIEF-Ophthotech Targets Gene Therapy To Expand Its Orphan And Age-Related Retinal Disease Strategy", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "ophthotech corp", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Ophthotech Corp:\n* OPHTHOTECH TARGETS GENE THERAPY TO EXPAND ITS ORPHAN AND AGE-RELATED RETINAL DISEASE STRATEGY\n* OPHTHOTECH - ‍ENTERED SERIES OF SPONSORED RESEARCH AGREEMENTS WITH UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL AND ITS HORAE GENE THERAPY CENTER​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T19:39:00.000+02:00", "crawled": "2018-02-28T13:07:09.055+02:00", "highlightTitle": ""}